Drugs and Devices
by Jenna Ogilvie | Dec 17, 2018 | Discussion Paper, Perspectives
Introduction Breast cancer is the most common malignancy among women in the United States, with over 260,000 new cases and over 40,000 deaths estimated to occur in 2018 [1]. Although most breast cancers are diagnosed with disease localized to the breast or breast... 
by Jenna Ogilvie | Dec 3, 2018 | Discussion Paper, Perspectives
The central idea of early disease detection and treatment is essentially simple. However, the path to its successful achievement (on the one hand, bringing to treatment those with previously undetected disease, and, on the other, avoiding harm to those persons not... 
by Jenna Ogilvie | Oct 22, 2018 | Commentary, Perspectives
Controlling or reducing the risk for cancer was a principal goal of the National Cancer Act, signed by President Nixon in 1971. Long before the human genome was sequenced, and the etiology of many cancers was understood, Americans were determined to find a way to... 
by Jenna Ogilvie | Oct 1, 2018 | Commentary, Perspectives
Upon arriving in Kenya in 1987, I was a well-trained parasitologist who knew nothing about development, economics, political systems, or structural poverty. Kenya, however, became my classroom. The focus three decades ago was to attack one disease at a time, to... 
by Molly Doyle | Mar 19, 2018 | Discussion Paper, Perspectives
Emerging Opportunities for Digital Health Digital health technologies have emerged in recent years, providing opportunities for engaging with consumers and integrating with the health care system to realize precision medicine, defined as “an evidence-based approach... Page 1 of 712345...»Last » 